We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$927M
AUM Growth
-$1.43M
Cap. Flow
+$7.24M
Cap. Flow %
0.78%
Top 10 Hldgs %
60.5%
Holding
125
New
10
Increased
26
Reduced
9
Closed
9

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$9.37M
2
WAB icon
Wabtec
WAB
+$5.68M
3
PG icon
Procter & Gamble
PG
+$4.97M
4
GIS icon
General Mills
GIS
+$3.54M
5
CELG
Celgene Corp
CELG
+$3.18M

Sector Composition

Rank Sector Weight
1 Financials 39.92%
2 Healthcare 20.04%
3 Industrials 8.62%
4 Materials 5.03%
5 Technology 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JKHY icon
51
Jack Henry & Associates
JKHY
$10.9B
$2M 0.22%
13,700
CHL
52
DELISTED
China Mobile Limited
CHL
$2M 0.22%
48,300
EWY icon
53
iShares MSCI South Korea ETF
EWY
$25.9B
$1.7M 0.18%
30,150
+23,100
+328% +$1.28M
AVXL icon
54
Anavex Life Sciences
AVXL
$325M
$1.48M 0.16%
468,110
+294,030
+169% +$848K
STOR
55
DELISTED
STORE Capital Corporation
STOR
$1.37M 0.15%
36,700
KHC icon
56
Kraft Heinz
KHC
$29.2B
$1.32M 0.14%
47,250
+5,800
+14% +$167K
VHT icon
57
Vanguard Health Care ETF
VHT
$19B
$1.12M 0.12%
6,690
ZTS icon
58
Zoetis
ZTS
$31.1B
$1.12M 0.12%
9,000
NDAQ icon
59
Nasdaq
NDAQ
$53.1B
$1.11M 0.12%
33,600
EOLS icon
60
Evolus
EOLS
$551M
$1.07M 0.12%
68,500
RVNC
61
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.04M 0.11%
80,100
MET icon
62
MetLife
MET
$61.5B
$979K 0.11%
+20,760
New +$990K
CL icon
63
Colgate-Palmolive
CL
$73.6B
$956K 0.1%
13,000
-129,090
-91% -$9.37M
NOV icon
64
NOV
NOV
$7.49B
$931K 0.1%
43,900
ALPN
65
DELISTED
Alpine Immune Sciences Inc
ALPN
$735K 0.08%
185,587
+64,224
+53% +$276K
BTI icon
66
British American Tobacco
BTI
$122B
$714K 0.08%
19,350
IFF icon
67
International Flavors & Fragrances
IFF
$21.7B
$665K 0.07%
5,420
+2,150
+66% +$274K
DNOW icon
68
DNOW Inc
DNOW
$3.01B
$639K 0.07%
55,675
OMC icon
69
Omnicom Group
OMC
$23.6B
$632K 0.07%
8,070
BRK.B icon
70
Berkshire Hathaway Class B
BRK.B
$1.11T
$562K 0.06%
2,700
FSTX
71
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$554K 0.06%
40,229
+24,895
+162% +$410K
STLA icon
72
Stellantis
STLA
$20.5B
$432K 0.05%
+33,350
New +$446K
ALDX icon
73
Aldeyra Therapeutics
ALDX
$91.1M
$422K 0.05%
80,020
+35,500
+80% +$191K
ECL icon
74
Ecolab
ECL
$79.8B
$416K 0.04%
2,100
WW
75
DELISTED
WW International
WW
$401K 0.04%
10,600

Similar funds

Hikari Power's Q3 2019 Portfolio in Review

As of Q3 2019, Hikari Power held 125 positions worth $927M, down 0.15% from $928M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q3 2019 filing shows 10 new, 26 increased, 9 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M. The largest sale was Colgate-Palmolive, an estimated $9.37M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2019 buy was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M.
  • Hikari Power added most to Wells Fargo in Q3 2019, an estimated $9.14M increase.
  • Hikari Power's biggest Q3 2019 reduction was Colgate-Palmolive, cutting an estimated $9.37M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2019, selling an estimated $495K.
  • Hikari Power's ten largest holdings make up 61% of its $927M portfolio in Q3 2019.
  • Hikari Power opened 10 new positions and closed 9 in Q3 2019.
  • Hikari Power's portfolio value fell 0.15% quarter-over-quarter to $927M.

Based on Hikari Power's 13F filing for Q3 2019, filed 31 Oct 2019.